Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel ferrocene-based PNO ligand patent CN113004341B enables high-selectivity asymmetric hydrogenation for cost-effective pharmaceutical intermediate manufacturing and supply chain stability.
Patent CN103664511B reveals tubular diazotization for high-purity intermediate. Enhances supply chain stability and reduces manufacturing costs significantly.
Novel patent CN103880770B enables high-purity chiral morpholine intermediates with reduced costs and scalable supply chain solutions for global pharmaceutical partners.
Novel patent CN116554040A details safe aminotetraethylene glycol synthesis. Enhances supply chain reliability and reduces manufacturing risks for global pharmaceutical intermediate procurement.
Advanced synthesis of chiral tetrahydroquinoline derivatives via diastereomeric resolution. Reliable supplier for scalable API intermediates with optimized cost structures.
Patent CN111575334B reveals a stable immobilized enzyme method for synthesizing chiral alcohols, offering significant cost reduction and supply reliability for API manufacturing.
Patent CN114277006A reveals a novel alcohol dehydrogenase for synthesizing chiral heterocyclic alcohols without organic solvents, offering significant supply chain and cost advantages.
Novel Grignard-based route for C11 aldehyde production offers high purity and yield, enabling cost-effective Vitamin A acetate manufacturing.
Patent CN117051052A reveals high-purity NEB-8 synthesis via MrADH. Offers supply chain reliability and significant cost reduction in pharmaceutical intermediate manufacturing processes.
Patent CN117737149A details enzymatic synthesis for high-purity S-vitronectin. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101392225B details a recombinant yeast method for high-purity statin intermediates, offering significant cost reduction in API manufacturing and supply chain reliability.
Patent CN113185443A reveals a green copper-catalyzed route for ketorolac intermediates, offering high purity and significant cost reduction in API manufacturing.
Patent CN101962661B reveals high-efficiency carbonyl reductase for statin intermediates. Offers superior yield and cost reduction in pharmaceutical intermediate manufacturing.
Advanced solid-phase synthesis of liraglutide intermediates using microwave technology. Delivers high purity, reduced costs, and reliable supply chain solutions.
Novel synthesis route for 2,3-diamino-4-bromopyridine offers high yield and cost efficiency for kinase inhibitor manufacturing supply chains and global procurement.
Patent CN103408459B details a high-yield route for 4-cyanophenylalanine. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel patent CN108912030A offers high-purity Imrecoxib synthesis with reduced cost and scalable supply chain reliability for pharmaceutical manufacturing.
Patent CN102675168A details a high-ee iridium-catalyzed allylation method for chiral thioethers, offering superior regioselectivity and mild conditions for API intermediates.
Patent CN117285537B reveals high-purity Upatinib synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN109384659B reveals a green synthesis route for Vitamin K3 using phthalic diesters, eliminating heavy metal waste and offering significant cost reduction in pharmaceutical intermediate manufacturing.